ArticleAlzheimer's research & therapy2026
Metabolic parameter variability, brain structure, perfusion, and cognition: a population-based study.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundMetabolic instability can affect cognitive function, but the mechanisms are largely unknown. To address this, we investigated the association between metabolic parameter variability, brain volume, cerebral blood flow (CBF), and cognitive performance, and evaluated whether CBF and brain volume mediate this relationship.
methodsParticipants were prospectively included from the Kailuan study. Between 2006 and 2020, the variability in metabolic parameters such as systolic blood pressure, fasting blood glucose, low-density lipoprotein cholesterol, and body mass index was evaluated using the coefficient of variation (CV). Starting in 2020, brain MRI and the Montreal Cognitive Assessment (MoCA) were performed continuously as part of the seventh follow-up visit and subsequent assessments. Generalized linear regression models were used to analyze the associations between metabolic variability, CBF, brain volume, and cognitive performance. Mediation analysis was performed to evaluate the mediation effects of CBF or brain volume.
resultsA total of 1894 participants (mean age, 55.4 ± 10.9 years; 51.8% male) were included. High variability scores of metabolic parameters were associated with lower CBF in total brain (β [95% confidence interval]: -2.02 [-3.73, -0.30]), total white matter (WM) (-3.04 [-4.72, -1.37]), temporal lobe (-1.82 [-3.60, -0.03]), and hippocampus (-1.91 [-3.65, -0.17]), as well as decreased volume in both total gray matter (GM) (-5.64 [-11.24, -0.04]) and temporal lobe (-1.70 [-3.16, -0.25]). High variability in metabolic parameters was associated with reduced MoCA scores (-0.98 [-1.75, -0.20]). After multiple comparison correction, the association with total WM CBF remained significant. Decreased brain volume and CBF were associated with reduced MoCA scores (P < 0.05). Mediation analysis revealed that the association between variability in metabolic parameters and MoCA scores was mediated by total WM CBF, total GM volume, and temporal lobe volume, accounting for 7.518%, 5.619%, and 6.864% of the effect, respectively.
conclusionReduced total WM CBF, GM volume, and temporal lobe volume mediated the association between elevated metabolic variability and cognitive decline, with total WM CBF showing the most robust mediating effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.